Literature DB >> 10201994

Unique superantigen activity of staphylococcal exfoliative toxins.

S R Monday1, G M Vath, W A Ferens, C Deobald, J V Rago, P J Gahr, D D Monie, J J Iandolo, S K Chapes, W C Davis, D H Ohlendorf, P M Schlievert, G A Bohach.   

Abstract

Certain strains of Staphylococcus aureus express one or both of two related, but immunologically distinct, exfoliative toxins (ETA and ETB). These toxins induce the symptoms associated with staphylococcal scalded skin syndrome. Both ETs have been shown to stimulate T cell proliferation. Recently, it was reported that ETA is a superantigen that stimulates T cells bearing human Vbeta2 or several murine Vbetas. However, other investigators have proposed that the superantigenicity reported for ETA resulted from contaminants in commercial preparations. This present study addresses those conflicting reports by assessing the biological and immunologic activities of highly purified rETs. ETA and ETB required APCs to induce selective polyclonal expansion of several human Vbetas (huVbetas), although, neither toxin expanded huVbeta2. ETB induced expansion of murine T cells bearing Vbetas 7 and 8, those that have the highest homology to the huVbetas expanded by ETA and ETB. Although flow cytometry of ETB-stimulated T cells matched PCR results, stimulation by ETA reduced percentages of T cells positive for several huVbetas that had been shown to have increased levels of mRNA transcripts. ETA and ETB induced contrasting reactions in vivo. In rabbits, ETB was moderately pyrogenic and enhanced susceptibility to lethal shock, while ETA lacked both activities. Predictions based on comparisons with other superantigens suggest molecular regions potentially involved in receptor binding in the ETA crystal structure and a modeled ETB three-dimensional structure. These results show that ETs are superantigens with unique properties that could account for the discrepancies reported.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1999        PMID: 10201994

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Structural similarities and differences in Staphylococcus aureus exfoliative toxins A and B as revealed by their crystal structures.

Authors:  A C Papageorgiou; L R Plano; C M Collins; K R Acharya
Journal:  Protein Sci       Date:  2000-03       Impact factor: 6.725

2.  Staphylococcal exfoliative toxins cleave alpha- and beta-melanocyte-stimulating hormones.

Authors:  J V Rago; G M Vath; T J Tripp; G A Bohach; D H Ohlendorf; P M Schlievert
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

3.  Recombinant Staphylococcus aureus exfoliative toxins are not bacterial superantigens.

Authors:  L R Plano; D M Gutman; M Woischnik; C M Collins
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

4.  Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome.

Authors:  M Roggiani; J A Stoehr; S B Olmsted; Y V Matsuka; S Pillai; D H Ohlendorf; P M Schlievert
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

Review 5.  Staphylococcus aureus superantigens and airway disease.

Authors:  Claus Bachert; Philippe Gevaert; Paul van Cauwenberge
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

6.  Clinical manifestations of staphylococcal scalded-skin syndrome depend on serotypes of exfoliative toxins.

Authors:  Osamu Yamasaki; Takayuki Yamaguchi; Motoyuki Sugai; Colette Chapuis-Cellier; François Arnaud; François Vandenesch; Jerome Etienne; Gerard Lina
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

7.  Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates.

Authors:  S Holtfreter; D Grumann; M Schmudde; H T T Nguyen; P Eichler; B Strommenger; K Kopron; J Kolata; S Giedrys-Kalemba; I Steinmetz; W Witte; B M Bröker
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

Review 8.  Exfoliative toxins of Staphylococcus aureus.

Authors:  Michal Bukowski; Benedykt Wladyka; Grzegorz Dubin
Journal:  Toxins (Basel)       Date:  2010-05-25       Impact factor: 4.546

Review 9.  Superantigens in human disease.

Authors:  A Bernal; T Proft; J D Fraser; D N Posnett
Journal:  J Clin Immunol       Date:  1999-05       Impact factor: 8.542

Review 10.  Superantigens and nasal polyps.

Authors:  Claus Bachert; Thibaut van Zele; Philippe Gevaert; Lore De Schrijver; Paul Van Cauwenberge
Journal:  Curr Allergy Asthma Rep       Date:  2003-11       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.